Modest HIV protection confirmed

With the full results of the Thai HIV vaccine trial released this morning (October 20) at a conference in Paris, the HIV/AIDS research community can breathe a sigh of relief: The vaccine candidate does appear to offer a real, albeit modest, level of protection against HIV infection. Human Immunodeficiency VirusImage: Wikimedia commons, NIAID"What we saw today was a more complete presentation of different types of analyses that were done, [and] the scientific conclusions are as they were describ

Jef Akst
Jef Akst

Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf...

View full profile.


Learn about our editorial policies.

Oct 19, 2009
With the full results of the Thai HIV vaccine trial released this morning (October 20) at a conference in Paris, the HIV/AIDS research community can breathe a sigh of relief: The vaccine candidate does appear to offer a real, albeit modest, level of protection against HIV infection.
Human Immunodeficiency Virus
Image: Wikimedia commons,
NIAID
"What we saw today was a more complete presentation of different types of analyses that were done, [and] the scientific conclusions are as they were described earlier," said virologist linkurl:Gary Nabel,;http://www3.niaid.nih.gov/labs/aboutlabs/VRC/virologyAndVectorCoreLaboratories/ director of the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases in Bethesda, Md., who did not participate in the research. "This really is a landmark study for HIV vaccine research." After the linkurl:preliminary results were released;http://www.the-scientist.com/blog/display/55995/ late last month, linkurl:many raised concerns;http://www.the-scientist.com/blog/display/56052/ about whether the 31% decrease in HIV infection risk shown by the vaccine candidate was genuine or...
New England Journal of Medicine (NEJM)NEJM



Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?